EXPLORE MORE
Monday on BPR:
NAACP’s Michael Curry
Journalist Mark Liebovich
Boston Medical Center’s Dr. Katherine Gergen Barnett
BlueHub CEO Elyse Cherry with housing advocate Rose Webster-Smith
Recent segments
-
Ending blood donation bans on gay and bisexual men is a win, but blood remains scarce
The FDA’s new blood donation guidelines favor specificity over broad bans. -
Boston's theater scene comes to life in four local productions
From Broadway adaptations to original plays, there's lots happening around town. -
Bruce Marks wants you to buy — or build — a home
A new initiative from NACA will help residents own their own pre-fab homes. -
Campbell optimistic new Police Accountability Unit will foster ‘systemic conversations’
Attorney General Andrea Campbell addressed excessive force in policing during “Ask the AG” on Boston Public Radio. -
Why documentarian Oliver Stone says now is the time for nuclear power
“Nuclear Now” uncovers the nuclear industry in France, Russia and the United States. -
New report finds Boston falls short on meeting early childhood education needs
15,000 children under the age of 5 are left without access to early childhood education and care because of a lack of available seats.
Listen to previous shows
-
Best Of BPR 3/24: Lamentations Of An Aztec Philosopher-King & Can Ozempic Treat All Manner Of Addiction?
Today: Amherst College's Ilan Stavans discusses his new book "Lamentations of Nezahualcóyotl: Nahuatl Poems" - a re-telling of an Aztec king's writings, translated directly from the indigenous language.And, Nicholas Reville, CEO of the nonprofit Center for Addiction Science, Policy & Research argues there’s potential for GLP-1 drugs to revolutionize addiction treatment. -
BPR Full Show 3/24: Jim Threatens To Sell His Tesla
Boston University journalism department head Brian McGrory discusses the release of the 'John' names in the brothel case, the CIA-related disclosures from JFK files and how media coverage of COVID-19 may have damaged people's trust in institutions.Amherst College's Ilan Stavans discusses his new book "Lamentations of Neahualcoyotl: Nahuatl Poems" and how Mexico's president Claudia Sheinbaum is handling Trump.Nicholas Reville, CEO and co-founder of CASPR (Center for Addiction Science, Policy & Research) discusses how GLP-1s and other weight-loss products can also be effective for treating addiction.Richard Davey, head of MassPort, discusses the agency's expansion of climate and environmental staffing and raising fees on rideshares to Logan Airport. -
Best Of BPR 3/21: Judge Gertner Rings Democracy Alarm Bells & The Zahili Zamora Trio
Today:Retired federal judge Nancy Gertner rings alarm bells on Trump's attack of the American legal system, comparing his intimidation and consolidation of power to that of Hungary's Viktor Orban.And, Cuban-born jazz pianist Zahili Zamora joins for Live Music Friday, at the Boston Public Library. -
BPR Full Show 3/21: Acts of Kindness
Live Music Friday with Cuban-born jazz pianist and Berklee professor Zahili Zamora. She's performing next Thursday at Long Live Roxbury Brewing Company. NBC Boston commentator Sue O’Connell discusses the latest news on the Karen Read trial, including blogger "Turtleboy" pleading not guilty to witness intimidation charges. Retired federal judge Nancy Gertner reacts to Justice Roberts’ rebuke of Trump on the issue of judicial impeachment, and more on Trump ignoring judicial orders. Our 'Press Play' media segment with GBH's Adam Reilly and Callie Crossley on the media's coverage of the Trump administration and coverage of the Boston mayoral race. -
Best Of BPR 3/20: Mahmoud Khalil's First Amendment Case & Tesla's Market Slump
Today:Columbia’s Mahmoud Khalil is being held in Louisiana, awaiting his fate after the federal government targeted him for his pro-Palestine advocacy – We speak with one of the members of his legal team, the head of the New York Civil Liberties Union, Donna Lieberman.Dan Primack is the business editor at Axios. He discusses the latest on interest rates and the fed – holding steady at least for now -- and the fate of Tesla.